Mason Edwards

Former Founder, X Palantir, X Google & Angel Investor working in AI as a PM

📍 United Kingdom🔄 Updated September 2026💼 1 investments📅 4 years investing🗓 Last invested Aug 2022
Operator-angel🌍 United Kingdom
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
4y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Aug 2022
DOGAMÍ is an entertainment company that develops web3 games centered around the Dogamí, mystical 3D dog avatars imbued with spiritual powers. The core product is DOGAMÍ Academy, a hybrid management mobile game available on iOS and Android app stores, in which users can train their Dogamí, participate in mystical obstacle courses, and win $DOGA tokens in competitive PVP events. The companys growth is supported by a $14M investment from industry leaders like Ubisoft, Animoca Brands, XAnge, The Sandbox cofounders…. DOGAMÍ is one of the biggest gaming projects on the Tezos and Polygon blockchain with a community of more than 200,000 gamers, and 24,000 NFTs sold.
Experience · 2 entries
All (2)
Investments (1)
Founder (1)
2022
Investor
Aug 2022
DOGAMÍ is an entertainment company that develops web3 games centered around the Dogamí, mystical 3D dog avatars imbued with spiritual powers. The core product is DOGAMÍ Academy, a hybrid management mobile game available on iOS and Android app stores, in which users can train their Dogamí, participate in mystical obstacle courses, and win $DOGA tokens in competitive PVP events. The companys growth is supported by a $14M investment from industry leaders like Ubisoft, Animoca Brands, XAnge, The Sandbox cofounders…. DOGAMÍ is one of the biggest gaming projects on the Tezos and Polygon blockchain with a community of more than 200,000 gamers, and 24,000 NFTs sold.
2011
Cofounder and CTO
Oct 2011
Synbiota radically reduces barrier-to-entry for creating blockbuster Life Science products by virtualizing the entire research and development pipeline. With Synbiota, anyone with a web-connected device, and a desire to change the world can leverage Biotechnology to create disruptive applications and products in medicine, materials, food and fuel. Using Synbiota, groups of any size, or even an individual can, with the click of a button, create a virtual research institute complete with DNA development tools, integrated data storage and management, colleagues, secure communication, attribution, IP, and performance metrics. Available now at www.synbiota.com
early stageBiotechnology